14M142: Abstracts: T Cell Biology and Targets in Autoimmune and Inflammatory Disease (2183–2186)

Abstract Moderator(s)

• TL

  Terri Laufer, MD

  University of Pennsylvania
  Bala Cynwyd, PA, United States

  Disclosure(s): No financial relationships to disclose
• 

  Vasileios Kyttaris, MD, PhD

  BIDMC
  Boston, MA, United States

  Disclosure(s): No financial relationships to disclose

Oral abstract session.

Presentations:

• 3:00 PM – 3:10 PM Eastern Time

  mTORC2 Contributes to Murine Systemic Autoimmunity
  

  Presenting Author: Hu Zeng, PhD – Mayo Clinic
• 3:10 PM – 3:15 PM Eastern Time

  Q&A
  
• 3:15 PM – 3:25 PM Eastern Time

  CaMK4 Controls the Humoral Response via the T Follicular Helper Compartment and Regulates Autoimmunity
  

  Presenting Author: Marc Scherlinger, MD, PhD – Beth Israel Deaconess Medical Center Harvard University
• 3:25 PM – 3:30 PM Eastern Time

  Q&A
  
• 3:30 PM – 3:40 PM Eastern Time

  Development of a Novel Regulatory T Cell-Based Therapy for Patients with Rheumatoid Arthritis
  

  Presenting Author: Anne-Renee van der Vuurst de Vries, PhD – Sonoma Biotherapeutics
• 3:40 PM – 3:45 PM Eastern Time

  Q&A
  
• 3:45 PM – 3:55 PM Eastern Time

  Cellular and Humoral Responses Following SARS-CoV-2 mRNA Vaccination in Patients on PD-1 Immunotherapy with irAEs
  

  Presenting Author: Sokratis Apostolidis, MD – University of Pennsylvania
• 3:55 PM – 4:00 PM Eastern Time

  Q&A